Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPRX
3401
DELISTED
Catalyst Pharmaceutical
CPRX
| $5.72M | ﹤0.01% |
235,872
+136,659
| +138% | +$3.08M |
|
3402
PUT
PTC Therapeutics
PTCT
$5.85B
| $5.72M | ﹤0.01% |
112,200
-96,000
| -46% | -$4.79M |
|
3403
First Trust Financials AlphaDEX Fund
FXO
$1.13B
| $5.72M | ﹤0.01% |
107,831
+102,520
| +1,930% | +$5.61M |
|
3404
PUT
Ball Corp
BALL
$16.9B
| $5.71M | ﹤0.01% |
109,700
+22,100
| +25% | +$1.16M |
|
3405
Onto Innovation
ONTO
$16.6B
| $5.71M | ﹤0.01% |
47,035
+32,794
| +230% | +$5.52M |
|
3406
CALL
Knight Transportation
KNX
$10.9B
| $5.71M | ﹤0.01% |
131,200
-283,800
| -68% | -$14.6M |
|
3407
Carlyle Group
CG
$17.5B
| $5.7M | ﹤0.01% |
130,820
+105,919
| +425% | +$5.25M |
|
3408
iShares Core Dividend ETF
DIVB
$1.92B
| $5.7M | ﹤0.01% |
117,499
+96,712
| +465% | +$4.74M |
|
|
RNAM
3409
DELISTED
Avidity Biosciences
RNAM
| $5.7M | ﹤0.01% |
193,063
+118,171
| +158% | +$3.68M |
|
|
GTM
3410
ZoomInfo Technologies
GTM
$1.22B
| $5.69M | ﹤0.01% |
569,287
+232,963
| +69% | +$2.44M |
|
3411
Zurn Elkay Water Solutions
ZWS
$7.97B
| $5.69M | ﹤0.01% |
172,542
+111,518
| +183% | +$4.02M |
|
|
CUK
3412
DELISTED
Carnival PLC
CUK
| $5.67M | ﹤0.01% |
323,300
-83,785
| -21% | -$1.8M |
|
3413
PUT
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.14B
| $5.67M | ﹤0.01% |
193,800
+64,100
| +49% | +$1.82M |
|
3414
CALL
InterDigital
IDCC
$8.65B
| $5.66M | ﹤0.01% |
27,400
+15,900
| +138% | +$3.2M |
|
3415
PUT
Vodafone
VOD
$37.1B
| $5.66M | ﹤0.01% |
604,100
-139,300
| -19% | -$1.22M |
|
3416
PUT
Equinor
EQNR
$98.2B
| $5.66M | ﹤0.01% |
214,000
-101,500
| -32% | -$2.46M |
|
3417
CALL
Invesco CurrencyShares British Pound Sterling Trust
FXB
$65.1M
| $5.66M | ﹤0.01% |
45,500
+34,100
| +299% | +$4.14M |
|
3418
Bank of Hawaii
BOH
$3.05B
| $5.66M | ﹤0.01% |
82,062
+57,766
| +238% | +$4.1M |
|
3419
iShares Micro-Cap ETF
IWC
$1.5B
| $5.66M | ﹤0.01% |
51,020
+41,845
| +456% | +$5.21M |
|
3420
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$54.6B
| $5.66M | ﹤0.01% |
70,373
-24,939
| -26% | -$2.18M |
|
3421
NexGen Energy
NXE
$6.97B
| $5.65M | ﹤0.01% |
1,259,329
+842,085
| +202% | +$4.98M |
|
3422
Itron
ITRI
$4.27B
| $5.65M | ﹤0.01% |
53,974
+32,801
| +155% | +$3.44M |
|
|
VTLE
3423
CALL
DELISTED
Vital Energy
VTLE
| $5.65M | ﹤0.01% |
266,300
+4,600
| +2% | +$133K |
|
3424
PUT
VanEck Agribusiness ETF
MOO
$1.02B
| $5.65M | ﹤0.01% |
83,200
-25,100
| -23% | -$1.7M |
|
3425
PUT
Polaris
PII
$3.63B
| $5.65M | ﹤0.01% |
137,900
+32,800
| +31% | +$1.56M |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.